The Potential of Bone Marrow Stem Cells to Correct Liver Dysfunction in a Mouse Model of Wilson's Disease

Metabolic liver diseases are excellent targets for correction using novel stem cell, hepatocyte, and gene therapies. In this study, the use of bone marrow stem cell transplantation to correct liver disease in the toxic milk (tx) mouse, a murine model for Wilson's disease, was evaluated. Preconditioning with sublethal irradiation, dietary copper loading, and the influence of cell transplantation sites were assessed. Recipient tx mice were sublethally irradiated (4 Gy) prior to transplantation with bone marrow stem cells harvested from normal congenic (DL) littermates. Of 46 transplanted tx mice, 11 demonstrated genotypic repopulation in the liver. Sublethal irradiation was found to be essential for donor cell engraftment and liver repopulation. Dietary copper loading did not improve cell engraftment and repopulation results. Both intravenously and intrasplenically transplanted cells produced similar repopulation successes. Direct evidence of functionality and disease correction following liver repopulation was observed in the 11 mice where liver copper levels were significantly reduced when compared with mice with no liver repopulation. The reversal of copper loading with bone marrow cells is similar to the level of correction seen when normal congenic liver cells are used. Transplantation of bone marrow cells partially corrects the metabolic phenotype in a mouse model for Wilson's disease.

[1]  F. Camargo,et al.  Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. , 2004, The Journal of clinical investigation.

[2]  M. Grompe.  The Role of Bone Marrow Stem Cells in Liver Regeneration , 2003, Seminars in liver disease.

[3]  Klaus Pfeffer,et al.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes , 2003, Nature.

[4]  George McNamara,et al.  Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. , 2003, Blood.

[5]  M. Grompe,et al.  Cell fusion is the principal source of bone-marrow-derived hepatocytes , 2003, Nature.

[6]  G. Vassilopoulos,et al.  Transplanted bone marrow regenerates liver by cell fusion , 2003, Nature.

[7]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[8]  M. Grompe,et al.  Kinetics of liver repopulation after bone marrow transplantation. , 2002, The American journal of pathology.

[9]  M. Nagao,et al.  Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. , 2002, Journal of hepatology.

[10]  Qi-Long Ying,et al.  Changing potency by spontaneous fusion , 2002, Nature.

[11]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[12]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[13]  R. Parton,et al.  Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase. , 2001, Human molecular genetics.

[14]  B. Vikram,et al.  Liver irradiation: a potential preparative regimen for hepatocyte transplantation. , 2001, International journal of radiation oncology, biology, physics.

[15]  K. Allen,et al.  Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. , 2000, The Biochemical journal.

[16]  Xin Wang,et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , 2000, Nature Medicine.

[17]  L. Jeng,et al.  Correlation of neurological manifestations and MR images in a patient with Wilson's disease after liver transplantation , 2000, Acta neurologica Scandinavica.

[18]  Rebekah Gardner,et al.  Liver from bone marrow in humans , 2000, Hepatology.

[19]  Sunil Badve,et al.  Derivation of hepatocytes from bone marrow cells in mice after radiation‐induced myeloablation , 2000, Hepatology.

[20]  M. Grompe,et al.  In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. , 1999, Blood.

[21]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[22]  M. Schaefer,et al.  Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver. , 1999, The American journal of physiology.

[23]  D W Cox,et al.  The toxic milk mouse is a murine model of Wilson disease. , 1996, Human molecular genetics.

[24]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[25]  A. Grimes,et al.  Hepatic metallothionein gene expression in toxic milk mice. , 1992, The Journal of nutrition.

[26]  R. Calne,et al.  Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation. , 1987, The Quarterly journal of medicine.

[27]  B. Weisner,et al.  CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation , 1987, Journal of the Neurological Sciences.

[28]  A. Mowat,et al.  Neurological Abnormalities in Wilson's Disease Are Reversible , 1987, Neuropediatrics.

[29]  R. Mehra,et al.  Effects of dietary copper supplementation of rats on the occurrence of metallothionein-I in liver and its secretion into blood, bile and urine. , 1986, The Biochemical journal.

[30]  H. Rauch.  Toxic milk, a new mutation affecting cooper metabolism in the mouse. , 1983, The Journal of heredity.

[31]  M. Beeler,et al.  Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. , 1974, Clinical chemistry.

[32]  I. Weissman,et al.  Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.

[33]  J. Mercer,et al.  The pathology and trace element status of the toxic milk mutant mouse. , 1994, Journal of comparative pathology.